Seventure Partners
Subsidiary of Natixis Investment Managers (Groupe BPCE)
Also known as Seventure
Paris VC founded in 1997, subsidiary of Natixis Investment Managers; invests in digital technologies and life sciences (incl. microbiome) via FCPIs and institutional funds; €1bn AUM (2024).
- HEADQUARTERS
- Paris, France
- FOUNDED
- 1997
- AUM
- €1B (2024)
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 5 people
Focus
- STAGES
- SeedSeries ASeries BGrowth
- ASSET MIX
- Venture capital
- GEOGRAPHY
- EuropeFranceGermany
Investment arms & vehicles
- Microbiome, health and nutrition funds (I: €160M; II raising, €200M target exceeded); LPs include Danone, Novartis, Bel, Tereos, Lesaffre
- Digital technologies (fintech, insurtech, regtech, retailtech) mainly in France and Germany
- Sport and well-being economy fund (target about €80M), launched with Caisse d'Epargne
- €56.1M seed fund (2013) for start-ups linked to 12 French academic partners
- Blue-economy thematic fund
Overview
Seventure Partners is a Paris venture capital management company created in 1997 and a subsidiary of Natixis Investment Managers (Groupe BPCE), approved by the AMF. It invests in innovative companies in digital technologies and life sciences, from seed to development capital, usually as lead financial investor with a board seat. It reported €1bn under management at 30 June 2024 and manages retail FCPIs (it launched the first FCPI in 1997) alongside institutional funds such as Health for Life Capital (microbiome), Digital Opportunities, Sport & Performance Capital and the Quadrivium 1 seed fund. It is based in Paris with offices in Munich, London, Geneva and Basel.
PORTFOLIO (11)
- argenxNOTABLEBiotech & Life Sciences · IPO
- ParrotNOTABLEDeep Tech
- ANote MusicFintech · since 2026
- ReboatClimate & Energy · since 2026
- vorteX-ioClimate & Energy · since 2026
- Vedanta BiosciencesBiotech & Life Sciences
- EnteromeBiotech & Life Sciences
- MaaT PharmaBiotech & Life Sciences
- FoodsmartHealthTech
- SantarisBiotech & Life Sciences · Acquired
- TalentsoftSoftware & SaaS
People
- Isabelle de CremouxChair of the Management Board (Présidente du directoire), Head of Life Sciences · source
- David ManjarresHead of Digital Technologies department · source
- Emmanuel FiessingerPartner (Directeur Associé), Life Sciences · source
- Bruno RivetPartner (Directeur Associé), Digital Technologies / Sport · source
- Pierre AumeunierChief Financial Officer · source
Links
Frequently asked questions
Seventure Partners is a VC fund based in Paris, France, founded in 1997.
Yes. Seventure Partners invests its own capital in private companies.
Seventure Partners invests at Seed, Series A, Series B and Growth stages in Biotech & Life Sciences, HealthTech, Food & Agriculture, Fintech, Software & SaaS and Climate & Energy.
Key people at Seventure Partners include Isabelle de Cremoux (Chair of the Management Board (Présidente du directoire), Head of Life Sciences), David Manjarres (Head of Digital Technologies department), Emmanuel Fiessinger (Partner (Directeur Associé), Life Sciences) and Bruno Rivet (Partner (Directeur Associé), Digital Technologies / Sport).
Seventure Partners's investments include argenx, Parrot, ANote Music, Reboat, vorteX-io, Vedanta Biosciences, Enterome and MaaT Pharma, among others.
The most recent publicly reported investment by Seventure Partners is ANote Music (€2M round (co-led with ScaleFund)), announced in Sep 2026.
Seventure Partners states that it accepts submissions through its official contact page.
Yes. Seventure Partners manages capital from outside investors.